March 3, 2026

Haemorrhagic events in patients with transthyretin cardiac amyloidosis

Key Points

Bleeding complications are common in patients with transthyretin cardiac amyloidosis and are linked to higher HAS-BLED scores.
A HAS-BLED score of 2 or higher significantly increases the risk of haemorrhagic events in affected individuals.
Analysis indicates that anticoagulation use further elevates the risk of bleeding in this patient population.
These findings may inform risk stratification and therapeutic decisions for managing transthyretin cardiac amyloidosis.

Abstract

bleeding is a frequent complication in ATTR-CA, with a higher risk in those individuals with a HAS-BLED score ≥2 and/or on AC. These findings could be considered in risk stratification and therapeutic decision-making.

Bookmark

Cite This Study

Cortés et al. (Mon,) studied this question.

synapsesocial.com/papers/69a75afec6e9836116a2185f https://doi.org/https://doi.org/10.1080/13506129.2025.2612282

Bookmark